tradingkey.logo

USANA Q2 adjusted profit beats estimate

ReutersJul 22, 2025 8:25 PM


Overview

  • USANA fiscal Q2 net sales grow 11% yr/yr, beating analyst expectations, per LSEG data

  • Adjusted EPS for fiscal Q2 rises to $0.74, exceeding estimates, per LSEG data

  • Company reiterates fiscal year 2025 outlook, despite decline in active customers


Outlook

  • USANA reiterates fiscal 2025 net sales outlook of $920 mln to $1 bln

  • Company expects fiscal 2025 adjusted EPS of $2.35 to $3.00

  • USANA anticipates 8% to 17% sales growth in fiscal 2025

  • Hiya sales expected to grow 29% to 42% in fiscal 2025


Result Drivers

  • COMMERCIAL STRATEGY - USANA attributes 11% net sales growth to its comprehensive commercial strategy, including enhanced incentives and brand messaging

  • HIYA PARTNERSHIP - Hiya's strong quarter driven by new partnership with Disney, boosting sales and subscriber growth

  • CUSTOMER DECLINE - Active customer numbers fell across regions, impacting overall performance


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Beat

$235.85 mln

$225.20 mln (1 Analyst)

Q2 Adjusted EPS

Beat

$0.74

$0.54 (1 Analyst)


Analyst Coverage

  • Wall Street's median 12-month price target for USANA Health Sciences Inc is $61.00, about 50.3% above its July 21 closing price of $30.29

  • The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release: ID:nBw7pmJNga

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI